Wolfgang J Wrasidlo

This inventor holds 52 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Neuropore Therapies, Inc., University of California, Brunswick Corporation. Active years: 1979-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang J Wrasidlo. Retrieved from https://idiyas.com/inventor/wolfgang-j-wrasidlo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 (Patent Applications = 13)

% Patents Active = 88.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 12)

Average Co-Inventor Count = 2.2

ph-index = 14

Forward Citations = 1,050(Granted Patents)

Forward Citations (Not Self Cited) = 1,007(Dec 10, 2025)

Location History:

LaJolla, CA (US) (2009)
San Diego, CA (US) (1989 - 2022)
La Jolla, CA (US) (1979 - 2024)

Company Filing History:

12 out of 12

Neuropore Therapies, Inc.

patents

11 out of 16,025

University of California

patents

10 out of 2,669

Brunswick Corporation

Memtec North America Corporation

Charité – Universitätsmedizin Berlin

patents

8. 1 out of 1

Global Cancer Technology Inc.

patent

9. 1 out of 1

Memetc North America Corp.

patent

10. 1 out of 22

Memtec America Corporation

Scripps Research Institute

Years Active: 1979-2026

Loading Chart...

Areas of Expertise:

Scintillator Nanocrystals

PI3-Kinase Modulators

Protein Aggregation Inhibitors

TLR Signaling

Melanoma Treatments

Heteroaryl Derivatives

Drug Encapsulation

Kinase Inhibitors

Vps34 Inhibitors

Vasculostatic Agents

Apoptosis Induction

Thin-Film Membranes

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637450 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2026-05-26),

2. 12168056 - Scintillator nanocrystal-containing compositions and methods for their use (2024-12-17),

3. 12049462 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2024-07-30),

4. 11708338 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2023-07-25),

5. 11492348 - Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways (2022-11-08),

6. 11345713 - Compounds as modulators of TLR2 signaling (2022-05-31),

7. 11299487 - Compounds and compositions as modulators of TLR signaling (2022-04-12),

8. 11236079 - Morpholine derivates as inhibitors of Vps34 (2022-02-01),

9. 11224656 - Scintillator nanocrystal-containing compositions and methods for their use (2022-01-18),

10. 11078196 - Heteroaryl amides as inhibitors of protein aggregation (2021-08-03),

11. 11008294 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2021-05-18),

12. 10975066 - Bis-heteroaryl derivatives as modulators of protein aggregation (2021-04-13),

13. 10864272 - Scintillator nanocrystal-containing compositions and methods for their use (2020-12-15),

14. 10501423 - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof (2019-12-10),

15. 10358443 - Heteroaryl amides as inhibitors of protein aggregation (2019-07-23),

Title: Unveiling the Innovations of Inventor Wolfgang J. Wrasidlo

Introduction:

Wolfgang J. Wrasidlo, a distinguished inventor based in La Jolla, CA, has made significant contributions to the field of pharmaceuticals with his extensive portfolio of 48 patents.

Latest Patents:

1. Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof: Wrasidlo's patent showcases substituted phenyl sulfonyl phenyl triazole thiones and their applications in pharmaceutical compositions and treatment methods.

2. Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways: Another groundbreaking patent by Wrasidlo focuses on tri-substituted aryl and heteroaryl derivatives, with implications in modulating PI3-kinase and autophagy pathways.

Career Highlights:

Throughout his career, Wrasidlo has been associated with esteemed companies such as Neuropore Therapies, Inc. and Brunswick Corporation. His innovative spirit and expertise have played a pivotal role in advancing pharmaceutical research and development.

Collaborations:

In his professional journey, Wrasidlo has collaborated closely with accomplished individuals in the field, including Emily M. Stocking and Frieder K. Hofmann. These collaborations have led to fruitful outcomes and groundbreaking inventions in the realm of pharmaceuticals.

Conclusion:

In conclusion, Wolfgang J. Wrasidlo stands as a visionary inventor who has significantly impacted the pharmaceutical industry with his groundbreaking patents and collaborative endeavors. His relentless pursuit of innovation continues to inspire and shape the future of pharmaceutical research and development.

Profile summary based on public USPTO records.